Ameritas Advisory Services’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $44.7K | Buy |
+85
| New | +$44.7K | ﹤0.01% | 1362 |
|
|
2024
Q4 | – | Sell |
-373
| Closed | -$392K | – | 917 |
|
|
2024
Q3 | $392K | Sell |
373
-8
| -2% | -$8.41K | 0.02% | 607 |
|
|
2024
Q2 | $400K | Buy |
381
+5
| +1% | +$5.26K | 0.02% | 648 |
|
|
2024
Q1 | $357K | Sell |
376
-32
| -8% | -$30.4K | 0.01% | 655 |
|
|
2023
Q4 | $371K | Buy |
408
+126
| +45% | +$115K | 0.02% | 498 |
|
|
2023
Q3 | $233K | Buy |
+282
| New | +$233K | 0.01% | 704 |
|
|
2023
Q2 | – | Sell |
-268
| Closed | -$216K | – | 2089 |
|
|
2023
Q1 | $216K | Sell |
268
-24
| -8% | -$19.3K | 0.01% | 742 |
|
|
2022
Q4 | $211K | Sell |
292
-6
| -2% | -$4.33K | 0.01% | 809 |
|
|
2022
Q3 | $205K | Buy |
+298
| New | +$205K | 0.01% | 706 |
|
|
2022
Q2 | – | Sell |
-416
| Closed | -$291K | – | 848 |
|
|
2022
Q1 | $291K | Buy |
416
+86
| +26% | +$60.2K | 0.01% | 671 |
|
|
2021
Q4 | $208K | Buy |
+330
| New | +$208K | 0.01% | 767 |
|